Re: development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration
- PMID: 18040264
- DOI: 10.1097/IAE.0b013e3180ca7daf
Re: development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration
Comment on
-
Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.Retina. 2006 Oct;26(8):859-70. doi: 10.1097/01.iae.0000242842.14624.e7. Retina. 2006. PMID: 17031284 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical